Michael Rocco

2.9k total citations · 2 hit papers
35 papers, 2.3k citations indexed

About

Michael Rocco is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Michael Rocco has authored 35 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Physiology. Recurrent topics in Michael Rocco's work include Lipoproteins and Cardiovascular Health (8 papers), Diet and metabolism studies (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Michael Rocco is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diet and metabolism studies (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Michael Rocco collaborates with scholars based in United States, Australia and Netherlands. Michael Rocco's co-authors include Geoffrey H. Tofler, Peter H. Stone, James E. Muller, Daniel Levy, Stefan N. Willich, John P. Kirwan, Elizabeth G. Nabel, Andrew P. Selwyn, Leslie Cho and Thomas P. J. Solomon and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Clinical Nutrition and Diabetes Care.

In The Last Decade

Michael Rocco

34 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circadian variation in the incidence of sudden cardiac death in the framingham heart study population

1987 512 citations Stefan N. Willich, Daniel Levy et al. The American Journal of Cardiology profile →
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

2014 421 citations Erik S.G. Stroes, David Colquhoun et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Rocco United States	21	947	782	522	334	288	35	2.3k
David Collier United Kingdom	28	2.1k 2.2×	602 0.8×	288 0.6×	532 1.6×	77 0.3×	82	3.6k
Toshio Kushiro Japan	23	1.0k 1.1×	382 0.5×	226 0.4×	431 1.3×	83 0.3×	108	1.8k
Beth A. Parker United States	28	1.7k 1.8×	1.1k 1.4×	748 1.4×	265 0.8×	219 0.8×	56	3.7k
Nina Rehnqvist Sweden	27	1.8k 1.9×	380 0.5×	261 0.5×	106 0.3×	178 0.6×	130	2.7k
Vito M. Campese United States	35	2.4k 2.5×	803 1.0×	575 1.1×	950 2.8×	78 0.3×	119	4.6k
William Malbecq United States	18	1.5k 1.6×	830 1.1×	249 0.5×	337 1.0×	220 0.8×	30	2.7k
Kalina Kawecka−Jaszcz Poland	30	2.7k 2.9×	546 0.7×	247 0.5×	565 1.7×	83 0.3×	244	3.7k
Furio Colivicchi Italy	29	2.5k 2.7×	1.6k 2.0×	220 0.4×	310 0.9×	266 0.9×	298	3.9k
Joji Ishikawa Japan	36	3.0k 3.2×	735 0.9×	429 0.8×	345 1.0×	45 0.2×	159	3.9k
Robert J. MacFadyen United Kingdom	27	1.8k 1.9×	435 0.6×	182 0.3×	394 1.2×	62 0.2×	88	2.8k

Countries citing papers authored by Michael Rocco

Since Specialization

Citations

This map shows the geographic impact of Michael Rocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rocco more than expected).

Fields of papers citing papers by Michael Rocco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rocco. The network helps show where Michael Rocco may publish in the future.

Co-authorship network of co-authors of Michael Rocco

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rocco. A scholar is included among the top collaborators of Michael Rocco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rocco. Michael Rocco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Solaru, Khendi White, et al.. (2016). PCSK9 inhibition: A promise fulfilled?. Cleveland Clinic Journal of Medicine. 83(11 suppl 2). S36–S44. 2 indexed citations

Clark, Donald, Danielle M. Brennan, Michael Rocco, Stanley L. Hazen, & Leslie Cho. (2016). CLINICAL CHARACTERISTICS ASSOCIATED WITH COMPLETE STATIN INTOLERANCE: THE CLEVELAND CLINIC EXPERIENCE. Journal of the American College of Cardiology. 67(13). 1895–1895. 2 indexed citations

Cho, Leslie, Michael Rocco, David Colquhoun, et al.. (2016). Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study. Cardiovascular Drugs and Therapy. 30(3). 297–304. 15 indexed citations

Cho, Leslie, Michael Rocco, David Colquhoun, et al.. (2014). Design and Rationale of the GAUSS‐2 Study Trial: A Double‐Blind, Ezetimibe‐Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects With Hypercholesterolemia Who Are Intolerant of Statin Therapy. Clinical Cardiology. 37(3). 131–139. 25 indexed citations

Cho, Leslie, et al.. (2014). New cholesterol guidelines: Worth the wait?. Cleveland Clinic Journal of Medicine. 81(1). 11–19. 22 indexed citations

Stroes, Erik S.G., David Colquhoun, David Sullivan, et al.. (2014). Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance. Journal of the American College of Cardiology. 63(23). 2541–2548. 421 indexed citations breakdown →

Malin, Steven K., et al.. (2013). β-Cell Dysfunction Is Associated with Metabolic Syndrome Severity in Adults. Metabolic Syndrome and Related Disorders. 12(2). 79–85. 36 indexed citations

Nock, Nora L., Cynthia Owusu, Emily L. Kullman, et al.. (2013). A Community-Based Exercise and Support Group Program in African-American Breast Cancer Survivors (ABCs). PubMed. 1(1). 15–24. 15 indexed citations

Mampuya, Warner, David J. Frid, Michael Rocco, et al.. (2013). Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience. American Heart Journal. 166(3). 597–603. 133 indexed citations

10.

Rocco, Michael. (2012). Statins and diabetes risk: Fact, fiction, and clinical implications. Cleveland Clinic Journal of Medicine. 79(12). 883–893. 17 indexed citations

11.

Kelly, Karen R., Jacob M. Haus, Thomas P. J. Solomon, et al.. (2011). A Low-Glycemic Index Diet and Exercise Intervention Reduces TNFα in Isolated Mononuclear Cells of Older, Obese Adults. Journal of Nutrition. 141(6). 1089–1094. 66 indexed citations

12.

Solomon, Thomas P. J., Jacob M. Haus, Karen R. Kelly, et al.. (2010). A low–glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. American Journal of Clinical Nutrition. 92(6). 1359–1368. 118 indexed citations

13.

Solomon, Thomas P. J., Jacob M. Haus, Karen R. Kelly, et al.. (2010). Improved Pancreatic β-Cell Function in Type 2 Diabetic Patients After Lifestyle-Induced Weight Loss Is Related to Glucose-Dependent Insulinotropic Polypeptide. Diabetes Care. 33(7). 1561–1566. 97 indexed citations

14.

Moore, Shirley M., Jacqueline M. Charvat, Nahida H. Gordon, et al.. (2006). Effects of a CHANGE intervention to increase exercise maintenance following cardiac events. Annals of Behavioral Medicine. 31(1). 53–62. 109 indexed citations

15.

Raby, Khether E., Joseph A. Vita, Michael Rocco, et al.. (1993). Changing vasomotor responses of coronary arteries to nifedipine. American Heart Journal. 126(2). 333–338. 3 indexed citations

16.

Rocco, Michael. (1990). Timing and triggers of transient myocardial ischemia. The American Journal of Cardiology. 66(16). G18–G21. 14 indexed citations

17.

Barry, Joan, et al.. (1988). Frequency of ST-segment depression produced by mental stress in stable angina pectoris from coronary artery disease. The American Journal of Cardiology. 61(13). 989–993. 92 indexed citations

18.

Willich, Stefan N., Daniel Levy, Michael Rocco, et al.. (1987). Circadian variation in the incidence of sudden cardiac death in the framingham heart study population. The American Journal of Cardiology. 60(10). 801–806. 512 indexed citations breakdown →

19.

Ribeiro, Jorge P., et al.. (1987). Periodic Breathing during Exercise in Severe Heart Failure. CHEST Journal. 92(3). 555–556. 58 indexed citations

20.

Campbell, Stephen, et al.. (1986). Active transient myocardial ischemia during daily life in asymptomatic patients with positive exercise tests and coronary artery disease. The American Journal of Cardiology. 57(13). 1010–1016. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact